Antacid

Zantac

Ranitidine and nizatidine, known respectively by their brand names Zantac and Axid, are commonly used drugs to treat heartburn, gastroesophageal reflux disease (GERD), and other stomach ulcer diseases. 

Earlier this year, an online pharmacy reported that they detected N-nitrosodimethylamine (NDMA) in ranitidine drugs on the U.S. market. After a preliminary investigation, the Food and Drug Administration (FDA) called for voluntary recalls of both ranitidine and nizatidine drugs that had unsafe levels of NDMA.

Introduced

1980s

Treats

Heartburn, GERD, stomach ulcer diseases

Side Effects

Exposure to NDMA

Read more about Zantac

A stock image of a woman with heartburn, representing Zantac lawsuit consolidation in California.

California Attorneys Seek to Consolidate Zantac Lawsuits

James Parker · June 12, 2020

Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Canadian flag representing the Zantac alternatives shortage in Canada.

Canada Faces a Zantac Alternatives Shortage

Benjamin Duong · February 11, 2020

Canada is facing shortages of heartburn medications after a Zantac recall led to an increase in demand for alternatives.

News
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a truck storing Zantac in the sun, as exposure to heat during storage and transportation causes the heartburn medication to become contaminated with NDMA.

Exposure to Heat During Storage Causes Zantac Contamination

Benjamin Duong · January 14, 2020

Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.

News
A photo of an Asian pharmacist removing medications from the pharmacy shelf, representing the recent news around the FDA Ranitidine recall.

More Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall

James Parker · January 13, 2020

Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.

FDA Regulation
A photo of a woman's hand as she hovers over a pill container thinking about which alternative to Zantac she should select.

5 Alternatives to Zantac

Benjamin Duong · January 7, 2020

What are the alternative options to treat heartburn and related conditions? Here are 5 medications to take instead of Zantac.

Health Features